SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-069142
Filing Date
2023-08-21
Accepted
2023-08-21 08:46:37
Documents
15
Period of Report
2023-08-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea183948-8k_adialpharm.htm   iXBRL 8-K 31710
2 PRESS RELEASE, ISSUED BY ADIAL PHARMACEUTICALS, INC. ON AUGUST 21, 2023 ea183948ex99-1_adialpharm.htm EX-99.1 24099
3 GRAPHIC ex99-1_001.jpg GRAPHIC 3998
  Complete submission text file 0001213900-23-069142.txt   288408

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE adil-20230821.xsd EX-101.SCH 3815
5 XBRL DEFINITION FILE adil-20230821_def.xml EX-101.DEF 26681
6 XBRL LABEL FILE adil-20230821_lab.xml EX-101.LAB 36807
7 XBRL PRESENTATION FILE adil-20230821_pre.xml EX-101.PRE 25305
9 EXTRACTED XBRL INSTANCE DOCUMENT ea183948-8k_adialpharm_htm.xml XML 5432
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38323 | Film No.: 231187424
SIC: 2834 Pharmaceutical Preparations